Frits van Rhee, MD
University of Arkansas · University of Arkansas for Medical Science-Myeloma Institute · UAMS
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Frits van Rhee, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:16 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04396496 · Treatment of POEMS Syndrome With DaratumumabUniversity of Arkansas · completed · POEMS Syndrome · principal investigator
- Ph2NCT03003728 · 2015-10: Expanded Natural Killer Cells and Elotuzumab for High-Risk Myeloma Post- Autologous Stem Cell Transplant (ASCT)University of Arkansas · withdrawn · Multiple Myeloma · principal investigator
- Ph2NCT03004287 · 2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance TherapyUniversity of Arkansas · active not recruiting · Multiple Myeloma · principal investigator
- Ph2NCT02192775 · UARK 2014-21 A Phase II Trial of Oncolytic Virotherapy by Systemic Administration of Edmonston Strain of Measles VirusUniversity of Arkansas · completed · Multiple Myeloma · principal investigator
- Ph2NCT02128230 · UARK 2012-02 Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete RemissionUniversity of Arkansas · terminated · Multiple Myeloma · principal investigator
- Ph2NCT00869232 · UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete RemissionUniversity of Arkansas · active not recruiting · Multiple Myeloma · principal investigator
- Ph2NCT00577512 · 2006-32 Phase II Study of Rapidly Recycled High Dose DTPACEUniversity of Arkansas · completed · Multiple Myeloma · principal investigator
- Ph1NCT00578045 · UARK 2006-28 Human Cord Blood Transplantation in Advanced Hematological MalignanciesUniversity of Arkansas · withdrawn · Multiple Myeloma · principal investigator
- Ph3NCT00574080 · UARK 2006-15: A Study of Tandem Transplants With or Without Bortezomib and ThalidomideUniversity of Arkansas · terminated · Multiple Myeloma · principal investigator
- Ph2NCT00113932 · UARK 2003-41: A Study of High-Dose Density Therapy in Patients With Multiple MyelomaUniversity of Arkansas · completed · Multiple Myeloma · principal investigator
- Ph1/Ph2NCT00113919 · UARK 2003-25: A Study of Intravenous (IV) Busulfan (Busulfex®) in Multiple Myeloma PatientsUniversity of Arkansas · terminated · Multiple Myeloma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:16 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in multiple myeloma.